Arrhythmia, Cardiac Function and Cardiogenic Shock

Search:

DAY

WEEK

MONTH

YEAR

Select your country:
Sign up | Log in

Arrhythmia

Cardiac Function

Cardiogenic Shock

Windtree’s Istaroxime Scores in Cardiogenic Shock Trial

CardiacWire

SEPTEMBER 25, 2024

Windtree Therapeutics’ istaroxime appears to have scored in its latest Phase 2b trial , showing that the steroidal drug significantly improves systolic blood pressure in cardiogenic shock patients. That could be a big deal in the cardiogenic shock space, which many believe is still in need of more effective treatments.

Cardiogenic Shock

Cardiogenic Shock Blood Pressure Heart Failure Cardiac Function

What are treatment options for this rhythm, when all else fails?

Dr. Smith's ECG Blog

JULY 21, 2024

The patient in today’s case presented in cardiogenic shock from proximal LAD occlusion, in conjunction with a subtotally stenosed LMCA. Cardiac function is poor, with akinesis of the LAD territory. However, he suddenly developed a series of malignant ventricular arrhythmias. RCA — 100% proximal occlussion.

Arrhythmia

Arrhythmia Cardiogenic Shock Bradycardia Defibrillator

Cardiovascular Update

Windtree’s Istaroxime Scores in Cardiogenic Shock Trial

What are treatment options for this rhythm, when all else fails?

Stay Connected